A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects

Mise à jour : Il y a 4 ans
Référence : NCT01520727

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study was to investigate the safety, tolerability, pharmacokinetics and catechol-O-methyltransferase (COMT) activity of BIA 9-1067 in healthy male subjects after single oral ascending doses.


Critère d'inclusion

  • Parkinson disease

Liens